Evidence map›Paper›PMID 36094091›Full record

ArticlemBio2022

Central Sugar Metabolism and the Cell Wall.

Hajar Yaakoub, Jean-Paul Latgé, Nicolas Papon

Abstract readComment
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. First genome report ofFrontiers in fungal biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Hajar YaakoubUniversité Angers-Université Brest Infections Respiratoires Fongiques, Structure Fédérative de Recherche "Interactions Cellulaires et Applications Thérapeutiques," Angers, France.
Jean-Paul LatgéUniversité Angers-Université Brest Infections Respiratoires Fongiques, Structure Fédérative de Recherche "Interactions Cellulaires et Applications Thérapeutiques," Angers, France.
Nicolas PaponUniversité Angers-Université Brest Infections Respiratoires Fongiques, Structure Fédérative de Recherche "Interactions Cellulaires et Applications Thérapeutiques," Angers, France.ORCID 0000-0001-6265-7321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human opportunistic pathogen Aspergillus fumigatus is recognized for its versatile cell wall when it comes to remodeling its components in adaptation to external threats, and this remodeling renders it refractory to antifungals targeting cell wall biosynthesis. A specific role for general sugar metabolism in the regulation of the synthesis of cell wall polymers has been previously demonstrated. Delving deeper into central sugar metabolism may reveal unexpected fundamental aspects in cell wall construction, as shown by the work of Zhou and coworkers (Y. Zhou, K. Yan, Q. Qin, O.G. Raimi, et al., mBio 13:e01426-22, 2022, https://doi.org/10.1128/mbio.01426-22) on the roles of the phosphoglucose isomerase of A. fumigatus in cell wall biosynthesis.

Indexed as

Aspergillus fumigatusCell WallFungal ProteinsSugarsAntifungal AgentsGlucose-6-Phosphate IsomerasePolymersVirulenceAntifungal AgentsFungal ProteinsGlucose-6-Phosphate IsomerasePolymersSugarsAspergilluscell wallhost-pathogen interactionsugar metabolismvirulence

Identifiers

PMID36094091
PMCPMC9600152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.